Qing Li

机构：Dalian Ocean University, Hebei Medical University, University of Hawaiʻi at Mānoa, The University of Sydney, Soochow University, Jiangxi Provincial Academy of Medical Sciences, First Affiliated Hospital of Jiangxi Medical College, Second Hospital of Hebei Medical University, Integrated Chinese Medicine (China), The First People's Hospital of Changzhou, Chuzhou University, Shanghai East Hospital, Second Affiliated Hospital of Nanjing Medical University, Crown Bioscience (China) · ORCID：0000-0003-2652-6070

发表论文 889 篇 · 总被引 20353 次 · h-index 69

代表论文

• Integrating single-cell RNA sequencing and artificial intelligence for multitargeted drug design for combating resistance in liver cancer (2025 · npj Precision Oncology · 被引 6)
• Systemic inflammation biomarkers can identify high tumor mutation burden in lung adenocarcinoma (2025 · BMC Cancer · 被引 4)
• Comprehensive analysis of metabolic and molecular alterations in the blood of patients with Sjögren’s syndrome based on untargeted metabolomics analysis (2025 · BMC Medical Genomics · 被引 2)
• Exploring the immunomodulatory mechanisms of Shiyiwei Shenqi tablets in NSCLC: N-acetylaspartate as a biomarker for modulating M1/M2 macrophage balance (2025 · Phytomedicine · 被引 2)
• Joint associations of grip strength, lipid levels, and lipid-related genetic risk with atrial fibrillation (2026 · Lipids in Health and Disease · 被引 1)
• Redox-responsive nanodrug enhances cascaded chemo-immunotherapy via tandem chemoresistant microbiome depletion and efferocytosis blockade (2025 · Chemical Engineering Journal · 被引 1)